首页> 外文期刊>Applied Medical Informatics >Prevalence of Metabolic Syndrome in an Adult Population from Targu Jiu
【24h】

Prevalence of Metabolic Syndrome in an Adult Population from Targu Jiu

机译:塔古久成年人口中代谢综合征的患病率

获取原文
           

摘要

Objective: The prevalence of the metabolic syndrome is rapidly increasing worldwide and in Romania, leading to increased morbidity and mortality due to type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). The purpose of this study was to assess the prevalence of the metabolic syndrome in an adult population from Targu Jiu. Material and Methods: A total of 2200 persons randomly selected from primary care, aged 25 years or older, were included in this study. Clinical, anthropometric characteristics and laboratory investigation results were assessed, as well as smoking status. Metabolic syndrome was diagnosed according to International Diabetes Federation (IDF) criteria or National Cholesterol Education Program- Adult Treatment Panel III (NCEP-ATP III) criteria. Results: The prevalence of the metabolic syndrome diagnosed according to IDF criteria was 28.4% (625 persons). The prevalence was lower when metabolic syndrome was defined according to ATP III criteria (24%). The prevalence of the metabolic syndrome increased with age, from around 10% in persons aged between 30-39 years to 40% in those aged between 60-69 years. Conclusions: These results from a representative sample of the adult population from Targu Jiu, show a high prevalence of metabolic syndrome. The large number individuals with the metabolic syndrome may have important implications for the health-care sector.
机译:目的:全球和罗马尼亚的代谢综合症患病率迅速上升,导致由于2型糖尿病(T2DM)和心血管疾病(CVD)引起的发病率和死亡率增加。这项研究的目的是评估在Targu Jiu的成年人口中代谢综合征的患病率。资料和方法:本研究包括从初次护理中随机选择的2200人,年龄在25岁以上。评估临床,人体测量学特征和实验室调查结果以及吸烟状况。代谢综合征是根据国际糖尿病联合会(IDF)标准或国家胆固醇教育计划-成人治疗小组III(NCEP-ATP III)标准诊断的。结果:根据IDF标准诊断出的代谢综合征患病率为28.4%(625人)。当根据ATP III标准定义代谢综合征时,患病率较低(24%)。代谢综合症的患病率随着年龄的增长而增加,从30-39岁之间的大约10%增加到60-69岁之间的40%。结论:这些来自塔古久成年人口的代表性样本的结果表明,代谢综合征的患病率很高。患有代谢综合征的大量个体可能对卫生保健部门产生重要影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号